Today: 7 February 2026
Subscribe
Browse Category

SWX:NOVN News 21 November 2025 - 7 February 2026

Novartis stock heads into Monday with Kisqali Canada nod and $23 billion U.S. R&D build-out in focus

Novartis stock heads into Monday with Kisqali Canada nod and $23 billion U.S. R&D build-out in focus

Novartis shares closed up 0.6% in Zurich at 119.96 francs Friday, with U.S. ADRs gaining 1.5%. The company broke ground on a new San Diego research center and reported a positive draft reimbursement recommendation for Kisqali in Canada. Investors are watching for the March 6 annual meeting and March 10 ex-dividend date tied to a proposed 3.70-franc payout.
7 February 2026
···
Novartis stock price: NOVN ends higher on FDA Breakthrough tag for Sjögren’s drug ianalumab — what to watch next week

Novartis stock price: NOVN ends higher on FDA Breakthrough tag for Sjögren’s drug ianalumab — what to watch next week

Novartis shares closed up nearly 1% at 115.60 francs in Zurich after U.S. regulators granted Breakthrough Therapy status to its Sjögren’s disease drug candidate, ianalumab. The Swiss Market Index fell 0.47%. Novartis plans global submissions for ianalumab in early 2026. U.S. markets will be closed Monday for Martin Luther King Jr. Day.
18 January 2026
··
Swiss Stock Market Today, November 18, 2025: SMI Slips as Roche Soars, ABB, Zurich and ams-Osram Drag the Index

Swiss Stock Market Today, 21 November 2025: SMI Holds Near Flat as Tech Slides and Defensives Lift Zurich

The Swiss stock market opened under pressure on Friday but quickly stabilised, with the Swiss Market Index (SMI) hovering just above the previous day’s close as investors rotated out of high‑flying tech names and into defensive blue chips. By mid‑morning in Zurich, the SMI was trading around 12,553 points, roughly 0.1% higher than Thursday’s close of 12,543, according to intraday data from cash.ch and MarketScreener. cash.ch+2MarketScreener UK+2 That modest gain came after futures had pointed to a drop of nearly three‑quarters of a percent earlier in the morning. finanzen.ch Global risk aversion, Fed uncertainty and a violent reversal in US
21 November 2025
······

Stock Market Today

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
GE Vernova stock closes up nearly 6% — what to watch before Monday’s trade

GE Vernova stock closes up nearly 6% — what to watch before Monday’s trade

7 February 2026
GE Vernova shares jumped 5.6% to $779.35 Friday as Wall Street rallied and the company reported 1.1 GW of U.S. wind repower orders for 2025. The company also closed its $5.3 billion purchase of the remaining Prolec GE stake and completed a $2.6 billion senior notes offering. Investors await next week’s U.S. jobs and inflation data.
Go toTop